Loading clinical trials...
Loading clinical trials...
Fludarabine Versus Fludarabine Plus Cyclophosphamide in First Line Therapy of Younger Patients (Up to 65 Years) With Advanced Chronic Lymphocytic Leukemia (CLL)
Conditions
Interventions
Fludarabine plus Cyclophosphamide
Fludarabine
Locations
135
Austria
Allgemeines Krankenhaus - Universitatskliniken
Vienna, Austria
Hanuschkrankenhaus
Vienna, Austria
Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie
Ansbach, Germany
Internistische Praxis - Arnstadt
Arnstadt, Germany
Specialist Practice for Oncology
Aschaffenburg, Germany
Klinikum Augsburg
Augsburg, Germany
Start Date
July 1, 1999
Primary Completion Date
July 1, 2003
Completion Date
July 1, 2007
Last Updated
May 23, 2019
NCT07277231
NCT05006716
NCT06859424
NCT05254743
NCT01804686
NCT05371808
Lead Sponsor
German CLL Study Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions